Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,251
archived clinical trials in
Pneumonia

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated:  2/17/2016
1780
mi
from 98109
Paris,
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated: 2/17/2016
1780
mi
from 98109
Paris,
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
1717
mi
from 98109
St. Louis, MO
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
1717
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from 98109
Lake Success, NY
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from 98109
Lake Success, NY
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
Scott & White Memorial Hospital
1740
mi
from 98109
Temple, TX
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
Scott & White Memorial Hospital
1740
mi
from 98109
Temple, TX
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Joseph's Hospital
2054
mi
from 98109
Hamilton,
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Joseph's Hospital
2054
mi
from 98109
Hamilton,
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
1717
mi
from 98109
St. Louis, MO
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
1717
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from 98109
Lake Success, NY
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from 98109
Lake Success, NY
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
Baylor Scott & White Health
1743
mi
from 98109
Temple, TX
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
Baylor Scott & White Health
1743
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2450
mi
from 98109
Gainesville, FL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2450
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2094
mi
from 98109
Hazard, KY
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2094
mi
from 98109
Hazard, KY
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2005
mi
from 98109
Lexington, KY
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2474
mi
from 98109
Burlington, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2474
mi
from 98109
Burlington, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2423
mi
from 98109
Springfield, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2423
mi
from 98109
Springfield, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1933
mi
from 98109
Detroit, MI
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1933
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1720
mi
from 98109
St. Louis, MO
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1720
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1376
mi
from 98109
El Paso, TX
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1376
mi
from 98109
El Paso, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
5132
mi
from 98109
Limoges,
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
5132
mi
from 98109
Limoges,
Click here to add this to my saved trials
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)
Status: Enrolling
Updated:  3/14/2016
Sparrow Hospital
1864
mi
from 98109
Lansing, MI
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)
Status: Enrolling
Updated: 3/14/2016
Sparrow Hospital
1864
mi
from 98109
Lansing, MI
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
University of California, San Diego
1049
mi
from 98109
San Diego, CA
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
University of California, San Diego
1049
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
West Suburban Hospital
1725
mi
from 98109
Oak Park, IL
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
West Suburban Hospital
1725
mi
from 98109
Oak Park, IL
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Foundation
1450
mi
from 98109
Rochester, MN
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Foundation
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
St. John's Mercy Medical Center
1708
mi
from 98109
St. Louis, MO
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
St. John's Mercy Medical Center
1708
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Audie Murphy VA Medical Center & University Hospital
1787
mi
from 98109
San Antonio, TX
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Audie Murphy VA Medical Center & University Hospital
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Emory Vaccine Center - The Hope Clinic
2182
mi
from 98109
Decatur, GA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Emory Vaccine Center - The Hope Clinic
2182
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
University of Iowa - Vaccine Research & Education Unit
1557
mi
from 98109
Iowa City, IA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
University of Iowa - Vaccine Research & Education Unit
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Saint Louis University - Center for Vaccine Development
1719
mi
from 98109
Saint Louis, MO
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Saint Louis University - Center for Vaccine Development
1719
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Cincinnati Children's Hospital Medical Center - Infectious Diseases
1967
mi
from 98109
Cincinnati, OH
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Cincinnati Children's Hospital Medical Center - Infectious Diseases
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center
1971
mi
from 98109
Nashville, TN
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Baylor College of Medicine - Molecular Virology and Microbiology
1890
mi
from 98109
Houston, TX
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Baylor College of Medicine - Molecular Virology and Microbiology
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
2
mi
from 98109
Seattle, WA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Immune Suppression and Ventilator Associated Pneumonias
Immune Suppression and Ventilator Associated Pneumonias
Status: Enrolling
Updated:  4/8/2016
Ohio State University
2006
mi
from 98109
Columbus, OH
Immune Suppression and Ventilator Associated Pneumonias
Immune Suppression and Ventilator Associated Pneumonias
Status: Enrolling
Updated: 4/8/2016
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
University of Louisville
1938
mi
from 98109
Louisville, KY
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
University of Louisville
1938
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Johns Hopkins
2329
mi
from 98109
Baltimore, MD
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Johns Hopkins
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Beth Israel
2402
mi
from 98109
New York, NY
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Beth Israel
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Summa Health System
2042
mi
from 98109
Akron, OH
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Summa Health System
2042
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ
1112
mi
from 98109
Phoenix, AZ
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Loma Linda Healthcare System, Loma Linda, CA
943
mi
from 98109
Loma Linda, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Loma Linda Healthcare System, Loma Linda, CA
943
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Long Beach Healthcare System, Long Beach, CA
982
mi
from 98109
Long Beach, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Long Beach Healthcare System, Long Beach, CA
982
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Palo Alto Health Care System, Palo Alto, CA
707
mi
from 98109
Palo Alto, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Palo Alto Health Care System, Palo Alto, CA
707
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA San Diego Healthcare System, San Diego, CA
1065
mi
from 98109
San Diego, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA San Diego Healthcare System, San Diego, CA
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials